Healthcare provider profile · identity verified

Swe Than, M.D.,PH.D

Internal Medicine · MODESTO, CA · NPI 1013368885

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	554	155
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	527	101
Lisinopril	Lisinopril	398	114
Levothyroxine Sodium	Levothyroxine Sodium	377	101
Amlodipine Besylate	Amlodipine Besylate	339	102
Losartan Potassium	Losartan Potassium	304	79
Gabapentin	Gabapentin	287	72
Omeprazole	Omeprazole	272	77
Metformin Hcl	Metformin Hcl	253	68
Pantoprazole Sodium	Pantoprazole Sodium	240	64
Albuterol Sulfate Hfa	Albuterol Sulfate	172	53
Metoprolol Succinate	Metoprolol Succinate	172	52
Sertraline Hcl	Sertraline Hcl	172	42
Alprazolam	Alprazolam	167	28
Tamsulosin Hcl	Tamsulosin Hcl	164	50
Hydrochlorothiazide	Hydrochlorothiazide	154	46
Furosemide	Furosemide	136	47
Potassium Chloride	Potassium Chloride	135	36
Simvastatin	Simvastatin	130	31
Eliquis	Apixaban	123	28
Escitalopram Oxalate	Escitalopram Oxalate	123	30
Fluticasone Propionate	Fluticasone Propionate	114	49
Trazodone Hcl	Trazodone Hcl	101	35
Alendronate Sodium	Alendronate Sodium	100	26
Buspirone Hcl	Buspirone Hcl	98	21
Carvedilol	Carvedilol	97	24
Metoprolol Tartrate	Metoprolol Tartrate	95	30
Ozempic	Semaglutide	90	11
Tizanidine Hcl	Tizanidine Hcl	87	14
Atenolol	Atenolol	81	19
Ibuprofen	Ibuprofen	77	30
Rosuvastatin Calcium	Rosuvastatin Calcium	77	20
Hydralazine Hcl	Hydralazine Hcl	76	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	31
Famotidine	Famotidine	69	21
Baclofen	Baclofen	68	25
Oxybutynin Chloride Er	Oxybutynin Chloride	68	21
Glimepiride	Glimepiride	67	21
Duloxetine Hcl	Duloxetine Hcl	66	17
Lovastatin	Lovastatin	65	15
Montelukast Sodium	Montelukast Sodium	65	22
Nifedipine Er	Nifedipine	63	20
Ondansetron Odt	Ondansetron	62	25
Allopurinol	Allopurinol	60	18
Ezetimibe	Ezetimibe	60	14
Pravastatin Sodium	Pravastatin Sodium	59	18
Hydroxyzine Hcl	Hydroxyzine Hcl	57	20
Fluoxetine Hcl	Fluoxetine Hcl	56	13
Estradiol	Estradiol	55	23
Lorazepam	Lorazepam	54	25
Tramadol Hcl	Tramadol Hcl	53	22
Clonidine Hcl	Clonidine Hcl	50	17
Fenofibrate	Fenofibrate	50	14
Oxycodone Hcl	Oxycodone Hcl	48	12
Prednisone	Prednisone	47	32
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Mirtazapine	Mirtazapine	46	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	14
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Azelastine Hcl	Azelastine Hcl	43	16
Pregabalin	Pregabalin	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	20
Temazepam	Temazepam	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	14
Glipizide	Glipizide	41	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	41	suppressed
Ketoconazole	Ketoconazole	41	14
Triamcinolone Acetonide	Triamcinolone Acetonide	40	21
Meclizine Hcl	Meclizine Hcl	38	18
Nystatin	Nystatin	38	13
Finasteride	Finasteride	37	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	37	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	14
Metformin Hcl Er	Metformin Hcl	35	13
Januvia	Sitagliptin Phosphate	34	suppressed
Hydrocortisone	Hydrocortisone	31	17
Nortriptyline Hcl	Nortriptyline Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Promethazine Hcl	Promethazine Hcl	30	24
Celecoxib	Celecoxib	29	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	14
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Acarbose	Acarbose	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Amoxicillin	Amoxicillin	23	22
Benazepril Hcl	Benazepril Hcl	23	suppressed
Cephalexin	Cephalexin	23	20
Gemfibrozil	Gemfibrozil	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Lidocaine	Lidocaine	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Megestrol Acetate	Megestrol Acetate	21	suppressed
Primidone	Primidone	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Ciclopirox	Ciclopirox Olamine	18	12
Glipizide Er	Glipizide	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Restasis	Cyclosporine	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Diazepam	Diazepam	17	suppressed
Nitroglycerin	Nitroglycerin	17	11
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Lamotrigine	Lamotrigine	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Topiramate	Topiramate	15	suppressed
Azithromycin	Azithromycin	14	13
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Nystop	Nystatin	13	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Carisoprodol	Carisoprodol	12	suppressed
Clonidine	Clonidine	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error